Mutations and/or dysregulation in DNA methylation will affect tumor progression, and Fan et al. (2019) found that the methylation level of the PTK2 promoter regulated the expression level of PTK2 in hepatocellular carcinoma. This evidence concerns the gene PTK2 and neoplasm.